These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 8225217)
41. Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy. Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Huang YH; Lee PC; Chang FY; Lee SD Liver Transpl; 2004 Dec; 10(12):1507-13. PubMed ID: 15558587 [TBL] [Abstract][Full Text] [Related]
42. Perioperative and long-term outcome of major hepatic resection for small solitary hepatocellular carcinoma in patients with cirrhosis. Lang BH; Poon RT; Fan ST; Wong J Arch Surg; 2003 Nov; 138(11):1207-13. PubMed ID: 14609868 [TBL] [Abstract][Full Text] [Related]
43. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation. Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284 [TBL] [Abstract][Full Text] [Related]
44. The use of percutaneous ethanol injection therapy for recurrence of hepatocellular carcinoma. Kotoh K; Sakai H; Morotomi I; Nawata H Hepatogastroenterology; 1995 Jul; 42(3):197-200. PubMed ID: 7590564 [TBL] [Abstract][Full Text] [Related]
46. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation. Takahashi S; Kudo M; Chung H; Inoue T; Nagashima M; Kitai S; Tatsumi C; Minami Y; Ueshima K; Fukunaga T; Haji S Dig Dis; 2007; 25(4):303-9. PubMed ID: 17960064 [TBL] [Abstract][Full Text] [Related]
47. Palliative surgical treatment for recurrent and non-resectable hepatocellular carcinoma. Imaoka S; Sasaki Y; Masutani S; Furukawa H; Ishikawa O; Kabuto T; Kameyama M; Koyama H; Iwanaga T Hepatogastroenterology; 1993 Aug; 40(4):342-6. PubMed ID: 7691700 [TBL] [Abstract][Full Text] [Related]
48. [Efficacy of transarterial embolization combined with percutaneous ethanol injection therapy for recurrent hepatocellular carcinoma]. Shimamura T; Une Y; Nakajima Y; Sato N; Matsushita M; Kamiyama T; Uchino J Gan To Kagaku Ryoho; 1994 Sep; 21(13):2229-32. PubMed ID: 7944447 [TBL] [Abstract][Full Text] [Related]
49. Percutaneous ethanol injection of hepatocellular carcinoma: survival after 3 years in 70 patients. Livraghi T Ital J Gastroenterol; 1992 Feb; 24(2):72-4. PubMed ID: 1315592 [TBL] [Abstract][Full Text] [Related]
50. [Prognostic factors of hepatocellular carcinomas after non-surgical treatment]. Kita K; Ebara M; Yoshikawa M; Sugiura N; Ohto M Gan To Kagaku Ryoho; 1995 Jun; 22(7):977-82. PubMed ID: 7794008 [TBL] [Abstract][Full Text] [Related]
51. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. Muto Y; Moriwaki H; Ninomiya M; Adachi S; Saito A; Takasaki KT; Tanaka T; Tsurumi K; Okuno M; Tomita E; Nakamura T; Kojima T N Engl J Med; 1996 Jun; 334(24):1561-7. PubMed ID: 8628336 [TBL] [Abstract][Full Text] [Related]
52. Primary hepatic cancer--the role of limited resection and total hepatectomy with orthotopic liver replacement. Funovics JM; Fritsch A; Herbst F; Piza F; Mühlbacher F; Längle F; Schemper M Hepatogastroenterology; 1988 Dec; 35(6):316-20. PubMed ID: 2850984 [TBL] [Abstract][Full Text] [Related]
54. Multimodality treatment in advanced primary liver cancer. Zhou XD; Tang ZY; Yu YQ; Yang BH; Lu JZ; Lin ZY; Ma ZC Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():286-9. PubMed ID: 7544966 [TBL] [Abstract][Full Text] [Related]
55. [Percutaneous ethanol injection (PEI) in the treatment of hepatocellular carcinoma]. Ebara M; Fukuda H; Yoshikawa M; Sugiura N; Saisho H Nihon Rinsho; 2001 Oct; 59 Suppl 6():545-51. PubMed ID: 11762009 [No Abstract] [Full Text] [Related]
56. [Surgical treatment of hepatocellular carcinoma]. Okamoto E; Yamanaka N; Kato T Gan To Kagaku Ryoho; 1989 Jan; 16(1):40-5. PubMed ID: 2536270 [TBL] [Abstract][Full Text] [Related]
57. [Treatment of hepatocellular carcinoma in the presence of liver cirrhosis]. Ducreux M; Elias D; Rougier P; Buffet C; Kac J; Fabri MC; Lasser P J Chir (Paris); 1995; 132(6-7):279-86. PubMed ID: 7499449 [TBL] [Abstract][Full Text] [Related]
58. [Ultrasound-guided percutaneous injection of alcohol. Is it an elective therapy in small diameter nodular hepatocarcinoma associated with cirrhosis?]. Salmi A Recenti Prog Med; 1989 Sep; 80(9):466-7. PubMed ID: 2556763 [TBL] [Abstract][Full Text] [Related]
59. [Strategy for the treatment of hepatocellular carcinoma]. Suenaga M; Sugiura H; Kokuba Y; Kurumiya T; Yamanaka H; Hatsuno T; Nobuta T Gan To Kagaku Ryoho; 1995 Jan; 22(1):45-51. PubMed ID: 7826077 [TBL] [Abstract][Full Text] [Related]